The popularity of the herbal supplement kratom has soared in recent years, with many people using the green plant powder to ease the symptoms of opioid withdrawal. Proponents of kratom argue that the largely unregulated substance could potentially solve the nation’s opioid crisis.
But government officials and drug abuse experts say kratom has no valid medical use and is just as addictive as stronger opioids. Kratom can even be deadly, according to the Food and Drug Administration. The government agency says the over-the-counter substance has been linked to 44 deaths since 2011.
What Is Kratom?
Kratom comes from the leaves of Mitragyna speciosa, a tree that grows in Thailand, Malaysia, Vietnam and other parts of Southeast Asia. The leaves of the tropical plant can be chewed, smoked or brewed into tea. Kratom powder can be ingested in pill form.
Depending on the dose taken, kratom can have almost polar opposite effects. In small doses, it acts as a stimulant, producing an energetic euphoria, increased alertness and talkativeness. But in higher doses, the drug acts more like a sedative and has strong painkilling properties.
- Nauclea speciosa
- Maeng da
- Mitragynine extract
- Red vein or white vein
In the United Kingdom, kratom is sometimes called “herbal speedball.”
The primary active ingredient in kratom is mitragynine. When mitragynine is broken down by the body, its major byproduct, or metabolite, is 7-hydroxymitragynine. Both chemicals act on the brain’s opioid receptors, causing a euphoric release of dopamine while dulling pain signals.
But experts who study kratom say its ingredients don’t bind to those receptors in exactly the same way as heroin, oxycodone and other opioids. As a result, kratom is much weaker. According to a 2016 study in the Journal of the American Chemical Society, 7-hydroxymitragynine is about one-tenth as potent as morphine, and mitragynine is about one-hundredth the strength of morphine.
Kratom does not require a prescription and is widely available except in five states and a handful of U.S. cities that have banned it. The supplement is commonly sold in tea bars, head shops, vape stores and online. Some convenience stores even carry it.
Kratom Uses & Risks
For hundreds of years, laborers in Southeast Asia have chewed on kratom leaves to boost energy and ease work-related muscle pain. Some people in Southeast Asia use it as an alternative to opium.
In the United States, kratom has become a popular herbal remedy to ease the symptoms of heroin and opioid withdrawal. In addition, some people use kratom to relieve chronic pain, depression and anxiety. Others use it recreationally to get a kratom high.
Kratom’s other purported medicinal uses include relieving inflammation, fever, cough and diarrhea.
According to the FDA, however, no reliable scientific evidence exists to support any therapeutic use of kratom, including its use as a treatment for opioid withdrawal symptoms.
The agency has also warned the public and health care professionals about the dangerous, and sometimes deadly, risks of using kratom. In a statement issued in February 2018, FDA Commissioner Scott Gottlieb declared that the chemical compounds in kratom are, in fact, opioids. He emphasized the potential for kratom addiction and abuse.
Kratom Side Effects
Kratom can cause a number of opioid-like side effects, including nausea, constipation, dry mouth, itching and a loss of appetite. Other kratom side effects can include sweating, increased urination, elevated heart rate, vomiting, drowsiness, weight loss, darkening of the skin, frequent urination and insomnia.
- Liver damage
- Hallucinations, delusions and confusion
- Cardiac arrest
Even small doses of kratom can cause uncomfortable side effects such as agitation and anxiety.
Consuming kratom regularly can lead to addiction and dependence. Chronic kratom users who suddenly stop using it may develop a multitude of uncomfortable withdrawal symptoms.
- Muscle aches
- Runny nose
- Cravings for the herb
As kratom use has soared over the past several years, so have calls to poison control centers. The Centers for Disease Control and Prevention noted a tenfold increase in calls about kratom to poison control centers between 2010 and 2015 — most of which came from health care providers.
The February 2018 alert from the FDA reported 44 deaths across the nation associated with kratom use.
Among them was Christopher Waldron, a 27-year-old Florida man who was found dead in his apartment on July 7, 2017. Waldron’s mother told a local television news station that her son had been struggling with an opioid addiction for more than a decade and was using the herb instead of prescription pain pills.
Following an autopsy, the Hillsborough County Medical Examiner ruled Waldron’s cause of death as “intoxication by Mitragynine (Kratom).”
Nancy Knoebel also lost her son to kratom. Andrew Turner, 27, was using kratom to treat heroin withdrawal symptoms, according to the Washington Post. The medical examiner concluded that he died from the “toxic effects” of the herb.
“If kratom hadn’t killed him, he’d be alive and sober,” Knoebel told the Washington Post. “It was like someone ran a red light and killed him.”
John and Lauren Eden blame kratom for their 22-year-old son’s death by suicide. Bags of the herb were found in his apartment after the University of Georgia junior shot himself with a .45 caliber handgun inside a gas station, according to the Atlanta Journal Constitution.
The American Kratom Association, however, has challenged the notion that kratom is a deadly substance. The group says that a number of the cases included in the FDA’s list of 44 kratom-linked fatalities were questionable and that other factors appear to have been involved in those deaths.
Kratom is currently banned in Alabama, Arkansas, Indiana, Tennessee, Wisconsin and several U.S. cities. It’s also a controlled substance in 16 countries, including Thailand and Malaysia.
While kratom is not currently regulated by the U.S. government, the Drug Enforcement Administration lists kratom as a “Drug of Concern,” along with DXM and Salvia divinorum.
The DEA attempted to classify kratom as a Schedule I controlled substance in 2016, but it halted the plan amid an outcry from members of Congress and proponents of the kratom industry.
As a former journalist and a registered nurse, Amy draws on her clinical experience, compassion and storytelling skills to provide insight into the disease of addiction and treatment options. Amy has completed the American Psychiatric Nurses Association’s course on Effective Treatments for Opioid Use Disorder and continuing education on Screening, Brief Intervention and Referral to Treatment (SBIRT). Amy is an advocate for patient- and family-centered care. She previously participated in Moffitt Cancer Center’s patient and family advisory program and was a speaker at the Institute of Patient-and Family-Centered Care’s 2015 national conference.
- Babu, K., McCurdy, C. & Boyer, E. (2009, January 20). Opioid receptors and legal highs: Salvia divinorum and Kratom. Retrieved from https://www.tandfonline.com/doi/abs/10.1080/15563650701241795
- Boodman, E. (2018, February 6). FDA calls kratom an ‘opioid’ and warns against using the supplement. Retrieved from https://www.statnews.com/2018/02/06/kratom-opioid-fda/
- Boyer, E. et al. (2008, June). Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth). Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670991/?version=meter+at+null&module=meter-Links&pgtype=article&contentId=&mediaId=&referrer=&priority=true&action=click&contentCollection=meter-links-click
- Centers for Disease Control and Prevention. (2016, July 29). Notes from the Field: Kratom (Mitragyna speciosa) Exposures Reported to Poison Centers — United States, 2010–2015. Retrieved from https://www.cdc.gov/mmwr/volumes/65/wr/mm6529a4.htm
- Drug Enforcement Administration. (2017). Drugs of Concern. Retrieved from https://www.dea.gov/pr/multimedia-library/publications/drug_of_abuse.pdf#page=84
- Drug Enforcement Administration. (2013, January). Kratom. Retrieved from https://www.deadiversion.usdoj.gov/drug_chem_info/kratom.pdf
- Gibbons, S. & Arunotayanun, W. (2013). Natural Product (Fungal and Herbal) Novel Psychoactive Substances. Retrieved from https://www.sciencedirect.com/topics/neuroscience/mitragyna-speciosa
- Harvard Law. (2018, February 8). Simulated Side Effects: FDA Uses Novel Computer Model to Guide Kratom Policy. Retrieved from http://blogs.harvard.edu/billofhealth/2018/02/08/fda-uses-novel-computer-simulation-to-guide-kratom-policy/
- Hilmas, C. & Fabricant, D. (2014). Biomarkers of toxicity for dietary ingredients contained in dietary supplements. Retrieved from https://www.sciencedirect.com/science/article/pii/B978012404630600035X
- Hughes, C. (2018, March 6). Cure or Kill: Dallasites Do Battle for Kratom, an Herbal Substitute for Narcotics the Feds May Ban. Retrieved from http://www.dallasobserver.com/news/dallas-people-join-the-fight-to-keep-kratom-legal-despite-the-dea-and-fda-10431405
- Kruegel, A. et al. (2016). Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators. Retrieved from https://pubs.acs.org/doi/abs/10.1021/jacs.6b00360?source=cen
- Lu, J. et al. (2014). Evaluation of the Cardiotoxicity of Mitragynine and Its Analogues Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275233/
- McGinley, L. (2018, February 6). FDA ramps up warnings about kratom, calling unregulated herb an ‘opioid.’ Retrieved from https://www.washingtonpost.com/news/to-your-health/wp/2018/02/06/fda-ramps-up-warnings-about-kratom-calling-unregulated-herb-an-opioid/?utm_term=.b0d4b6fc7ea5
- McGinley, L. & Zezima, K. (2018, February 10). Kratom is hailed as a natural pain remedy, assailed as an addictive killer. The U.S. wants to treat it like heroin. Retrieved from https://www.washingtonpost.com/national/health-science/kratom-is-hailed-as-a-natural-pain-remedy-assailed-as-an-addictive-killer-the-us-wants-to-treat-it-like-heroin/2018/02/10/aaf4bf7c-077e-11e8-b48c-b07fea957bd5_story.html?utm_term=.1b7fc505393b
- McWhirter, L. & Morris, S. (2010). A Case Report of Inpatient Detoxification after Kratom (Mitragyna speciosa) Dependence. Retrieved from https://www.karger.com/Article/Abstract/320288
- Paluska, M. (2017, September 29). Exclusive: Hillsborough CO. medical examiner confirms 1st death by herbal supplement kratom. Retrieved from https://www.abcactionnews.com/news/region-hillsborough/exclusive-hillsborough-confirms-first-ever-death-by-herbal-supplement-kratom-in-the-county
- Prozialeck, W., Jivan, J. & Andurkar, S. (2012, December). Pharmacology of Kratom: An Emerging Botanical Agent with Stimulant, Analgesic and Opioid-Like Effects. Retrieved from http://jaoa.org/article.aspx?articleid=2094342
- Rosenbaum, C., Carreiro, S. & Babu, K. (2012, March). Here Today, Gone Tomorrow…and Back Again? A Review of Herbal Marijuana Alernatives (K2, Spice), Synthetic Cathinones (Bath Salts), Kratom, Salvia divinorum, Methoxetamine, and Piperazines. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3550220/
- The National Center on Addiction and Substance Abuse. (2018, February 6). Harmful or Healing: What is Kratom? Retrieved from https://www.centeronaddiction.org/the-buzz-blog/harmful-or-healing-what-kratom
- U.S. Food & Drug Administration. (2018, February 26). FDA and Kratom. Retrieved from https://www.fda.gov/NewsEvents/PublicHealthFocus/ucm584952.htm
- U.S. Food & Drug Administration. (2018, February 26). FDA In Brief: FDA objects to kratom compound intended for use as an alternative to prescription opioids and promoted with unproven claims to treat addiction. Retrieved from https://www.fda.gov/NewsEvents/Newsroom/FDAInBrief/ucm598389.htm
- U.S. Food & Drug Administration. (2018, January 12). Kratom death adverse events report. Retrieved from https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/CDERFOIAElectronicReadingRoom/UCM595575.pdf
- U.S. Food & Drug Administration. (2018, February 6). Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse. Retrieved from https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm595622.htm
- U.S. Food & Drug Administration. (2017, November 14). Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA advisory about deadly risks associated with kratom. Retrieved from https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm584970.htm